Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OGTFinder: A Curated Growth Temperature Data Set and Its Application To Predict Optimal Growth Temperatures of Bacteria and Archaea.

Journal of chemical information and modeling·2026
Same author

Caesarean Scar Ectopic Pregnancy in Early Gestation: A Scoping Review of Definitions and Diagnostic Approach.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

ADNEX-AI: automated extraction of ultrasound predictors for interpretable ovarian cancer risk stratification.

NPJ precision oncology·2025
Same author

A Novel Peak-Shape Aware Approach for Mass Alignment in Mass Spectrometry.

Rapid communications in mass spectrometry : RCM·2025
Same author

A Core Outcome Set to Guide Future Research on Caesarean Scar Ectopic Pregnancy: COSCAR Consensus Study.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors.

iScience·2025

Related Experiment Video

Updated: May 27, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Improved modeling of clinical data with kernel methods.

Anneleen Daemen1, Dirk Timmerman, Thierry Van den Bosch

  • 1Department of Electrical Engineering, Katholieke Universiteit Leuven, and Department of Obstetrics and Gynecology, University Hospitals Leuven, 3001 Leuven, Belgium. anneleen.daemen@gmail.com

Artificial Intelligence in Medicine
|December 3, 2011
PubMed
Summary
This summary is machine-generated.

A novel clinical kernel function enhances patient similarity modeling by accounting for variable types and ranges. This improves diagnosis, prognosis, and therapy response prediction, outperforming traditional methods on diverse clinical datasets.

More Related Videos

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Related Experiment Videos

Last Updated: May 27, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Area of Science:

  • Computational biology
  • Medical informatics
  • Machine learning in healthcare

Background:

  • Clinical data, including age, gender, and medical history, are crucial for disease management.
  • High-throughput technologies generate vast datasets, but integrating diverse clinical parameters remains challenging.
  • Traditional kernel methods often fail to adequately model the heterogeneous nature of clinical data.

Purpose of the Study:

  • To develop and evaluate a novel kernel function specifically designed for mixed-type clinical data.
  • To improve the modeling of patient similarity by considering variable types and ranges.
  • To enhance the performance of machine learning models for clinical prediction tasks.

Main Methods:

  • Proposed a new kernel function tailored to the characteristics of clinical variables (type and range).
  • Integrated the novel kernel function into a least squares support vector machine (LS-SVM) framework.
  • Evaluated the kernel function's performance on four gynecological datasets and three breast cancer case studies, comparing it against standard kernel functions.

Main Results:

  • The proposed clinical kernel function demonstrated superior patient similarity representation by equalizing variable influence and incorporating range considerations.
  • Significantly improved diagnostic, prognostic, and therapy response prediction accuracy, evidenced by average increases in the area under the ROC curve (AUC) in gynecological datasets.
  • Enhanced performance in breast cancer case studies, particularly when combining clinical and expression data with a weighted approach favoring clinical parameters, achieving maximum AUC increases up to 0.127.

Conclusions:

  • The proposed kernel function offers a robust and effective alternative for linear and non-linear classification of clinical data with mixed variable types.
  • Accounting for variable type and range is essential for accurate patient similarity modeling in clinical applications.
  • This approach holds promise for advancing precision medicine by better leveraging comprehensive patient information.